Impact of 4,4’-(propanediamide)Dibenzoate Sodium on Manifestations of Experimental Non-Alcoholic Steatohepatitis
https://doi.org/10.33647/2074-5982-17-3-95-99
Abstract
The impact of a propanedioic acid derivative, 4,4’-(propanediamide)dibenzoate sodium (maloben), on the physiological and histological characteristics of mice line C57BL/6 was studied under 24-week modeled steatohepatitis. It was found that the compound in question exhibits hepatoprotective and regenerative properties, thus being promising for further study as an anti-steatosis agent.
About the Author
M. A. Belykh
Saint Petersburg State Chemical and Pharmaceutical University of the Ministry of Health Care of Russia
Russian Federation
Russian Federation
Maria A. Belykh
197376, Russian Federation, Saint Petersburg, Professora Popova Str., 14, lit. A
References
1. Bazhanova E.D., Okovitiy S.V., Belykh M.A. Vliyanie 4,4’-(propandiamido) dibenzonata natria I metformina na dinamiku apoptoza i profi leracii gepatocitov u myshei s saharnym diabetom I ojireniem [Effect of sodium 4,4’-(propanediamide)dibenzoate and metformin on the dynamics of apoptosis and proliferation of hepatocytes in mice with diabetes and obesity. Exp. and Clin. Pharm. 2018;81(5):17–20. (In Russian).
2. Drapkina O.M., Korneeva O.N. Kontihuum nealkogol’noy jirovoy bolezni pecheni: ot steatoza pecheni do serdechno-sosudistogo riska [Continium of non-alcoholic fatty liver disease from hepatic steatosis to cardiovascular risk. Rational Pharmacotherapy in Cardiology. 2016;12(4):424–429. (In Russian).
3. Labeznik L.B. Golovanova E.V., Turkina S.V., et al. Nealkogol’nay jirovya bolezn’ pecheni u vzroslyh: klinika, diagnostika, lechenie. Rekomend. Dlay terapevtov, tret’ya versiya [Non-alcoholic fatty liver disease in adults: clinic, diagnostic, treatment. Guidelines for therapists, third version. Clinical and Experimental Gastroenterology. 2021;185(1):4–52. (In Russian).
4. Okovitiy S.V. Kombinirovannoe primenenie gepatoprotektorov [Combined use of hepatoprotective agents. Lechashchiy vrach [Therapist]. 2020;(8):38–43. (In Russian).
5. Tin’kov A.A., Popova E.V., Nikonorov A.A. Vliyanie sul’fata jeleza na endokrinnuyu disfunkciyu jirovoi tkani krys linii Wistar [Infl uence of iron sulfate on adipose tissue endocrine dysfunction of Wistar rats. Kazan Medical Journal. 2013;5:760–763. (In Russian).
6. Dufour J.F., Caussy C., Loomba R. Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challenges. Gut. 2020;69(10):1877–1884.
7. Moon A.M., Singal A.G., Tapper E.B. Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis. Clin Gastroenterol Hepatol. 2020;18(12):2650–2666.
8. Xu B.L., Wang R., Ma L.N., Dong W., Zhao Z.W., Zhang J.S., Wang Y.L., Zhang X. Effects of caloric intake on learning and memory function in juvenile C57BL/6J mice BioMed research international. 2015.
Review
For citations:
Belykh M.A. Impact of 4,4’-(propanediamide)Dibenzoate Sodium on Manifestations of Experimental Non-Alcoholic Steatohepatitis. Journal Biomed. 2021;17(3):95-99. (In Russ.) https://doi.org/10.33647/2074-5982-17-3-95-99
Views:
271
Email this article 
